|
Elliott P, Charron P, Blanes JR, Tavazzi L, Tendera M, Konté M, Laroche C, Maggioni AP; EORP Cardiomyopathy Registry Pilot Investigators. European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology. Eur Heart J. 2016 Jan 7;37(2):164-73. doi: 10.1093/eurheartj/ehv497. Epub 2015 Sep 25. PubMed PMID: 26409010.
AÑO: 2016; IF: 19.651
|
|
San Román I, Navarro M, Martínez F, Albert L, Polo L, Guardiola J, García-Molina E, Muñoz-Esparza C, López-Ayala JM, Sabater-Molina M, Gimeno JR. Unclassifiable arrhythmic cardiomyopathy associated with Emery-Dreifuss caused by a mutation in FHL1. Clin Genet. 2016 Aug;90(2):171-6. doi: 10.1111/cge.12760. Epub 2016 Mar 23. PubMed PMID: 26857240.
AÑO: 2016; IF: 3.326
|
|
García-Molina E, Sabater-Molina M, Muñoz C, Ruiz-Espejo F, Gimeno JR. An R1632C variant in the SCN5A gene causing Brugada syndrome. Mol Med Rep. 2016 Jun;13(6):4677-80. doi: 10.3892/mmr.2016.5100. Epub 2016 Apr 11. PubMed PMID: 27082542.
AÑO: 2016; IF: 1.692
|
|
Ortiz-Genga MF, Cuenca S, Dal Ferro M, Zorio E, Salgado-Aranda R, Climent V, Padrón-Barthe L, Duro-Aguado I, Jiménez-Jáimez J, Hidalgo-Olivares VM, García-Campo E, Lanzillo C, Suárez-Mier MP, Yonath H, Marcos-Alonso S, Ochoa JP, Santomé JL, García-Giustiniani D, Rodríguez-Garrido JL, Domínguez F, Merlo M, Palomino J, Peña ML, Trujillo JP, Martín-Vila A, Stolfo D, Molina P, Lara-Pezzi E, Calvo-Iglesias FE, Nof E, Calò L, Barriales-Villa R, Gimeno-Blanes JR, Arad M, García-Pavía P, Monserrat L. Truncating FLNC Mutations Are Associated With High-Risk Dilated and Arrhythmogenic Cardiomyopathies. J Am Coll Cardiol. 2016 Dec 6;68(22):2440-2451. doi: 10.1016/j.jacc.2016.09.927. PubMed PMID: 27908349.
AÑO: 2016; IF: 19.896
|
|
Manrique-Rodriguez, S.; de la Rubia-Nieto, A.; Garcia-Robles, J. A.; Goicoechea-Diezhandino, M.; Gimeno-Blanes, J. A.; Pernia-Lopez, M. S.; Pellicer-Franco, C.; Sanjurjo-Saez, M.. Individualized therapy in patients with Fabry disease: is it a feasible strategy for rare diseases?. EXPERT OPINION ON ORPHAN DRUGS. DEC 2016; 4(12):1199-1206. 10.1080/21678707.2016.1253468
AÑO: 2016; IF: 0.559
|